CCI approves Piramal Enterprises- Pfizer deal

21 Sep 2016 Evaluate

Fair trade regulator Competition Commission of India (CCI) has approved Ajay Piramal-led Piramal Enterprises’ proposed acquisition of four brands from pharmaceutical major Pfizer.

As per the deal announced in May, Piramal Enterprises had entered into a deal with Pfizer to acquire Ferradol, Neko, Sloan’s and Waterbury’s Compound brands for Rs 110 crore. The deal also included trademark rights for Ferradol and Waterbury’s Compound in Bangladesh and Sri Lanka.

Piramal Enterprises is engaged in the business of pharmaceuticals, including research and development, financial services and information management through its subsidiaries.

Piramal Ent - Amalga Share Price

1124.60 0.00 (0.00%)
22-Sep-2025 16:59 View Price Chart
Peers
Company Name CMP
Bajaj Finance 984.10
Shriram Finance 989.70
Aditya Birla Capital 355.55
Chola Invest & Fin. 1705.00
Tata Capital 340.45
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×